P. Ron Ellis

All filings by P. Ron Ellis on record concern Endocyte Inc. In total, 3 filings cover trades dated from 4 February 2016 to 6 February 2016.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 8 February 2016 came the latest disclosure, a share grant in Endocyte Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.